Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP575443.RAE2f0GFkXc5WK7oYnrXwj94WTnwcuVT3SZNi7dDBf1og130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP575443.RAE2f0GFkXc5WK7oYnrXwj94WTnwcuVT3SZNi7dDBf1og130_assertion type Assertion NP575443.RAE2f0GFkXc5WK7oYnrXwj94WTnwcuVT3SZNi7dDBf1og130_head.
- NP575443.RAE2f0GFkXc5WK7oYnrXwj94WTnwcuVT3SZNi7dDBf1og130_assertion description "[These results suggest that OCIAD2 begins to express at the progression from in situ to invasive carcinoma, and is associated with the favorable prognosis of adenocarcinoma mixed subtype with BAC component.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP575443.RAE2f0GFkXc5WK7oYnrXwj94WTnwcuVT3SZNi7dDBf1og130_provenance.
- NP575443.RAE2f0GFkXc5WK7oYnrXwj94WTnwcuVT3SZNi7dDBf1og130_assertion evidence source_evidence_literature NP575443.RAE2f0GFkXc5WK7oYnrXwj94WTnwcuVT3SZNi7dDBf1og130_provenance.
- NP575443.RAE2f0GFkXc5WK7oYnrXwj94WTnwcuVT3SZNi7dDBf1og130_assertion SIO_000772 17054434 NP575443.RAE2f0GFkXc5WK7oYnrXwj94WTnwcuVT3SZNi7dDBf1og130_provenance.
- NP575443.RAE2f0GFkXc5WK7oYnrXwj94WTnwcuVT3SZNi7dDBf1og130_assertion wasDerivedFrom befree-2016 NP575443.RAE2f0GFkXc5WK7oYnrXwj94WTnwcuVT3SZNi7dDBf1og130_provenance.
- NP575443.RAE2f0GFkXc5WK7oYnrXwj94WTnwcuVT3SZNi7dDBf1og130_assertion wasGeneratedBy ECO_0000203 NP575443.RAE2f0GFkXc5WK7oYnrXwj94WTnwcuVT3SZNi7dDBf1og130_provenance.